|
VistideDrug - Vistide The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Cidofovir
Strength -
EQ 75MG BASE/ML
Applicant -
GILEAD
New Drug Application (NDA) Number -
020638
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 26, 1996
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Gilead Sciences Inc
Vistide
Loprox 0.77% Suspension; Topical
Vistide Eq 75mg Base/ml Injectable; Injection Ciclopirox 0.77% Cream; Topical Ciclopirox 0.77% Cream; Topical Loprox 0.77% Cream; Topical Loprox 0.77% Gel; Topical Loprox 1% Shampoo; Topical Penlac 8% Solution; Topical Ciclopirox 0.77% Suspension; Topical Ciclopirox 0.77% Suspension; Topical NewDrugInformation |